AURA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.90%

Insider Buying (Last 12 Months): $14,696,565.00

Insider Selling (Last 12 Months): $396,852.23

Aura Biosciences Insider Trading History Chart

Aura Biosciences Share Price & Price History

^$7.08

▼ -0.02 (-0.28%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.

Aura Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/23/2024	Julie B Feder	CFO	Sell	6,609	$7.64	$50,492.76	62,991
1/23/2024	Los Pinos Elisabet De	Insider	Sell	15,853	$7.64	$121,116.92	161,438
11/9/2023	Matrix Capital Management Comp	Major Shareholder	Buy	1,560,000	$9.00	$14,040,000.00	6,922,870
11/7/2023	David Michael Johnson	Director	Buy	76,000	$7.17	$544,920.00	126,066
11/6/2023	Julie B Feder	CFO	Sell	3,900	$12.07	$47,073.00	69,600
11/6/2023	Los Pinos Elisabet De	Insider	Sell	7,449	$12.03	$89,611.47	177,291
10/30/2023	Julie B Feder	CFO	Sell	3,385	$6.82	$23,085.70	69,600
10/30/2023	Los Pinos Elisabet De	Insider	Sell	9,586	$6.83	$65,472.38	180,940
10/3/2023	David Michael Johnson	Director	Buy	13,500	$8.27	$111,645.00	43,500
1/5/2023	David Michael Johnson	Director	Buy	396	$10.00	$3,960.00	17,300
12/28/2022	David Michael Johnson	Director	Buy	4,000	$9.75	$39,000.00	17,000
12/5/2022	Matrix Capital Management Comp	Major Shareholder	Buy	1,250,000	$12.00	$15,000,000.00	5,362,870
12/1/2022	David Michael Johnson	Director	Buy	10,000	$12.37	$123,700.00	15,000
10/31/2022	Cadmus Rich	Insider	Sell	1,672	$12.45	$20,816.40	24,578
10/31/2022	Julie B Feder	CFO	Sell	2,015	$12.45	$25,086.75	24,235
10/31/2022	Rosch Mark De	COO	Sell	1,115	$12.46	$13,892.90	16,385
6/13/2022	David Michael Johnson	Director	Buy	20,000	$13.99	$279,800.00	30,000
6/10/2022	David Michael Johnson	Director	Buy	10,000	$15.04	$150,400.00	10,000

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.

SEC Filings (Institutional Ownership Changes) for Aura Biosciences (NASDAQ:AURA)

96.75% of Aura Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aura Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2024	Eventide Asset Management LLC	5,802,682	$51.41M	0.8%	+91.8%	15.166%
2/14/2024	Platinum Investment Management Ltd.	180,145	$1.60M	0.1%	N/A	0.471%
2/13/2024	Matrix Capital Management Company LP	6,922,870	$61.34M	0.6%	+29.1%	18.094%
2/13/2024	Tower Research Capital LLC TRC	4,297	$38K	0.0%	-34.9%	0.011%
2/12/2024	Monashee Investment Management LLC	198,415	$1.76M	0.3%	N/A	0.519%
2/12/2024	Decheng Capital LLC	515,555	$4.57M	1.3%	N/A	1.348%
2/9/2024	TBH Global Asset Management LLC	60,322	$0.53M	0.1%	+82.3%	0.158%
2/9/2024	Franklin Resources Inc.	600,118	$5.32M	0.0%	N/A	1.569%
2/9/2024	Trexquant Investment LP	17,362	$0.15M	0.0%	+64.5%	0.045%
2/6/2024	Levin Capital Strategies L.P.	100,000	$0.89M	0.1%	+23.3%	0.261%
1/23/2024	Regency Capital Management Inc. DE	704,974	$6.25M	4.0%	+33.8%	1.843%
1/12/2024	SG Americas Securities LLC	19,140	$0.17M	0.0%	+52.0%	0.050%
1/5/2024	Exchange Traded Concepts LLC	14,899	$0.13M	0.0%	+34.0%	0.039%
12/6/2023	Citigroup Inc.	106,426	$0.96M	0.0%	-28.3%	0.278%
11/29/2023	Decheng Capital Management III Cayman LLC	1,163,123	$10.43M	2.6%	+296.5%	3.040%
11/15/2023	Rock Springs Capital Management LP	722,896	$6.48M	0.2%	-29.1%	1.889%
11/15/2023	Adage Capital Partners GP L.L.C.	2,875,000	$25.79M	0.1%	+6.1%	7.526%
11/14/2023	Eventide Asset Management LLC	3,024,905	$27.13M	0.5%	+3.0%	7.919%
11/9/2023	Citigroup Inc.	106,426	$0.96M	0.0%	-28.3%	0.279%
11/7/2023	Barclays PLC	4,874	$43K	0.0%	-82.5%	0.013%
11/2/2023	Regency Capital Management Inc. DE	526,978	$4.73M	4.0%	-1.0%	1.380%
10/31/2023	Levin Capital Strategies L.P.	81,095	$0.73M	0.1%	+15.9%	0.212%
10/27/2023	TD Asset Management Inc	107,912	$0.97M	0.0%	+100.0%	0.282%
10/13/2023	SG Americas Securities LLC	12,594	$0.11M	0.0%	N/A	0.033%
9/21/2023	Barclays PLC	27,852	$0.34M	0.0%	-19.1%	0.073%
8/10/2023	Citigroup Inc.	148,496	$1.83M	0.0%	-71.2%	0.393%
8/4/2023	American International Group Inc.	13,221	$0.16M	0.0%	+15.8%	0.035%
8/3/2023	Barclays PLC	27,852	$0.34M	0.0%	-19.1%	0.074%
8/2/2023	Values First Advisors Inc.	10,184	$0.13M	0.1%	+72.6%	0.027%
8/2/2023	Bank of Montreal Can	409,574	$5.21M	0.0%	N/A	1.084%
8/1/2023	Regency Capital Management Inc. DE	532,333	$6.57M	5.7%	-2.1%	1.408%
7/31/2023	Levin Capital Strategies L.P.	70,000	$0.86M	0.1%	+366.7%	0.185%
7/20/2023	Exchange Traded Concepts LLC	11,426	$0.14M	0.0%	N/A	0.030%
5/17/2023	Long Focus Capital Management LLC	171,377	$1.59M	0.1%	N/A	0.453%
5/12/2023	Long Focus Capital Management LLC	107,982	$1M	0.1%	N/A	0.286%
5/12/2023	Martingale Asset Management L P	20,354	$0.19M	0.0%	N/A	0.054%
5/11/2023	Citigroup Inc.	516,042	$4.79M	0.0%	+254.2%	1.365%
5/9/2023	TBH Global Asset Management LLC	33,097	$0.31M	0.1%	N/A	0.088%
5/8/2023	Regency Capital Management Inc. DE	543,675	$5.05M	6.1%	-1.9%	1.438%
5/4/2023	Barclays PLC	34,417	$0.32M	0.0%	-5.8%	0.091%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	11,659	$0.11M	0.0%	N/A	0.031%
4/28/2023	SG Americas Securities LLC	11,201	$0.10M	0.0%	N/A	0.030%
4/24/2023	Levin Capital Strategies L.P.	15,000	$0.14M	0.0%	N/A	0.040%
2/15/2023	Nantahala Capital Management LLC	798,751	$8.39M	0.5%	+108.1%	2.723%
2/14/2023	Water Island Capital LLC	23,500	$0.25M	0.0%	+119.6%	0.080%
2/13/2023	Matrix Capital Management Company LP	5,362,870	$56.31M	1.1%	+30.4%	18.285%
2/13/2023	Artal Group S.A.	410,000	$4.31M	0.2%	N/A	1.398%
2/9/2023	Decheng Capital Management III Cayman LLC	293,333	$3.08M	1.2%	+39.7%	1.000%
2/9/2023	Monashee Investment Management LLC	131,640	$1.38M	0.6%	N/A	0.449%
2/9/2023	Citigroup Inc.	145,704	$1.53M	0.0%	-2.7%	0.497%
2/7/2023	TD Asset Management Inc	53,956	$0.57M	0.0%	N/A	0.184%
2/1/2023	Bank of Montreal Can	19,429	$0.27M	0.0%	N/A	0.066%
1/27/2023	Regency Capital Management Inc. DE	554,286	$5.82M	6.7%	+146.8%	1.890%
11/14/2022	Water Island Capital LLC	10,700	$0.19M	0.0%	-26.4%	0.037%
11/14/2022	UBS Oconnor LLC	12,430	$0.23M	0.0%	-86.3%	0.042%
11/10/2022	Nantahala Capital Management LLC	383,764	$6.95M	0.5%	+11.8%	1.311%
11/4/2022	Regency Capital Management Inc. DE	224,554	$4.07M	5.0%	-11.8%	0.767%
8/15/2022	Nantahala Capital Management LLC	343,215	$4.86M	0.2%	+13.7%	1.173%
8/15/2022	Citadel Advisors LLC	2,312,159	$32.76M	0.0%	-0.2%	7.902%
8/3/2022	Regency Capital Management Inc. DE	254,622	$3.61M	3.9%	N/A	0.870%
5/10/2022	Decheng Capital Management III Cayman LLC	210,000	$4.62M	1.4%	N/A	0.719%
5/5/2022	New York State Common Retirement Fund	6,252	$0.14M	0.0%	+134.3%	0.021%
2/16/2022	Matrix Capital Management Company LP	4,112,870	$69.84M	0.8%	N/A	14.080%
2/15/2022	Adage Capital Partners GP L.L.C.	1,255,480	$21.32M	0.0%	N/A	4.298%
2/14/2022	Citadel Advisors LLC	2,315,102	$37.32M	0.0%	N/A	7.925%
2/11/2022	Allianz Asset Management GmbH	55,145	$0.94M	0.0%	N/A	0.189%
2/8/2022	Northern Trust Corp	45,875	$0.78M	0.0%	N/A	0.157%
2/3/2022	Medicxi Ventures Management Jersey Ltd	3,039,892	$51.62M	12.9%	N/A	10.407%
2/2/2022	New York State Common Retirement Fund	2,668	$45K	0.0%	N/A	0.009%

Data available starting January 2016

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $7.08

$6.87

$7.23

50 Day Range

MA: $7.97

$7.03

$9.24

52 Week Range

Now: $7.08

$5.99

$13.50

Volume

117,387 shs

Average Volume

169,147 shs

Market Capitalization

$350.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Aura Biosciences?: Aura Biosciences' top insider investors include:
Matrix Capital Management Comp (Major Shareholder)
Los Pinos Elisabet De (Insider)
David Michael Johnson (Director)
Julie B Feder (CFO)
Cadmus Rich (Insider)
Rosch Mark De (COO)
Learn More about top insider investors at Aura Biosciences.